Cardinal Health (CAH): financials, SEC filings and peers

Cardinal Health (CAH) is a health care distributors company in the Health Care sector of the S&P 500, headquartered in Dublin, Ohio.

It was founded in 1971 and joined the S&P 500 on May 27, 1997.

Its fiscal year ends in June, and its shares trade on the NYSE.

In its SEC filings it is classified as “Wholesale-Drugs, Proprietaries & Druggists' Sundries”.

Cardinal Health at a glance

Revenue (12 months): $244.7B
Revenue growth: +10.1%
Operating margin: 1.0%
Net income (12 months): $1.7B
Free cash flow (12 months): $5.5B
Cash: $2.8B
Debt: $9.0B
Diluted EPS (12 months): —

Twelve months to December 31, 2025, from the 10-Q filed February 5, 2026.

Latest twelve months

Over the twelve months to December 31, 2025, Cardinal Health reported revenue of $244.7 billion, up 10.1% from a year earlier.

Its operating margin was 1.0%: for every $100 of sales, about $1 was left as operating profit.

Net income was $1.7 billion (0.7% of revenue), 26.7% higher than a year earlier.

Operating cash flow was $6.1 billion and capital spending $597 million, leaving free cash flow of $5.5 billion (2.2% of revenue).

At the end of the period it held $2.8 billion in cash and $9.0 billion in debt, a net debt position of $6.3 billion.

The diluted share count fell 2.5% in a year, typically the result of buybacks.

Five-year trend

Revenue went from $162.5 billion in fiscal 2021 to $254.2 billion in fiscal 2026, about 9.4% a year.
Operating margin has been steady, around 1.0%.
Free cash flow was positive in each of the last 6 fiscal years.
Cardinal Health reported a net loss in 1 of the last 6 fiscal years.

Fiscal year	2022	2023	2024	2025	2026
Revenue	$181.3B	$205.0B	$226.8B	$222.6B	$254.2B
Revenue growth	11.6%	13.0%	10.7%	-1.9%	14.2%
Operating margin	-0.3%	0.4%	0.5%	1.0%	1.0%
Net income	−$938M	$330M	$852M	$1.6B	$1.7B
Free cash flow	$2.8B	$2.4B	$3.3B	$1.9B	$4.5B
Diluted EPS	$-3.37	$1.26	$3.45	$6.45	$7.23

Fiscal years as reported in Cardinal Health’s 10-K filings. Free cash flow is operating cash flow minus capital spending.

Recent SEC filings

10-K filed August 11, 2026 — annual report
8-K filed August 11, 2026 — Earnings results; Regulation FD disclosure
8-K filed August 11, 2026 — Material agreement; Agreement terminated
8-K filed August 5, 2026 — Executive or director change
10-Q filed April 30, 2026 — quarterly report
8-K filed April 30, 2026 — Earnings results; Regulation FD disclosure
8-K filed March 23, 2026 — Executive or director change; Regulation FD disclosure
8-K filed March 5, 2026 — Executive or director change

All Cardinal Health filings on SEC EDGAR

Companies like Cardinal Health

Other S&P 500 companies in Health Care Distributors:

More from Health Care

All 60 Health Care companies →

Questions about Cardinal Health

Is Cardinal Health's revenue growing?

Yes. Revenue for the twelve months to December 31, 2025 was $244.7 billion, up 10.1% from a year earlier, according to its SEC filings.

Is Cardinal Health profitable?

Yes. It earned $1.7 billion in net income over the twelve months to December 31, 2025, a net margin of 0.7%.

Does Cardinal Health have more cash or more debt?

At December 31, 2025 it had $2.8 billion in cash and $9.0 billion in debt, so more debt than cash.

When did Cardinal Health last file financial results?

Its latest annual report (10-K) was filed with the SEC on August 11, 2026.

Which companies are similar to Cardinal Health?

In the S&P 500, Cardinal Health is grouped in Health Care Distributors within the Health Care sector. Cencora (COR), Henry Schein (HSIC), McKesson Corporation (MCK) are in the same group.

Understand the numbers

Source: Cardinal Health’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved September 27, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.